JP2023521162A5 - - Google Patents
Info
- Publication number
- JP2023521162A5 JP2023521162A5 JP2022561996A JP2022561996A JP2023521162A5 JP 2023521162 A5 JP2023521162 A5 JP 2023521162A5 JP 2022561996 A JP2022561996 A JP 2022561996A JP 2022561996 A JP2022561996 A JP 2022561996A JP 2023521162 A5 JP2023521162 A5 JP 2023521162A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- sars
- cov
- respiratory syndrome
- international
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063008529P | 2020-04-10 | 2020-04-10 | |
| US63/008,529 | 2020-04-10 | ||
| US202063062623P | 2020-08-07 | 2020-08-07 | |
| US63/062,623 | 2020-08-07 | ||
| PCT/US2021/026303 WO2021207444A1 (en) | 2020-04-10 | 2021-04-08 | Methods of treating severe acute respiratory syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521162A JP2023521162A (ja) | 2023-05-23 |
| JP2023521162A5 true JP2023521162A5 (https=) | 2024-04-11 |
Family
ID=75690705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561996A Pending JP2023521162A (ja) | 2020-04-10 | 2021-04-08 | 重症急性呼吸器症候群を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12582633B2 (https=) |
| EP (1) | EP4132516A1 (https=) |
| JP (1) | JP2023521162A (https=) |
| KR (1) | KR20220167292A (https=) |
| CN (1) | CN115916189A (https=) |
| AU (1) | AU2021254415A1 (https=) |
| BR (1) | BR112022020107A2 (https=) |
| CA (1) | CA3174684A1 (https=) |
| IL (1) | IL296518A (https=) |
| MX (1) | MX2022012707A (https=) |
| WO (1) | WO2021207444A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12605364B2 (en) * | 2020-04-10 | 2026-04-21 | Eagle Pharmaceuticals, Inc. | Methods of treating SARS-CoV-2 infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY201417A (en) | 2017-10-20 | 2024-02-21 | Eagle Res Labs Limited | Dantrolene prodrugs and methods of their use |
| US11123328B2 (en) | 2017-11-14 | 2021-09-21 | University Health Network | Dantrolene and analogs thereof for the chronic treatment and prevention of dyssynchronous cardiac dysfunction |
| WO2019175761A1 (en) | 2018-03-12 | 2019-09-19 | Orbicular Pharmaceutical Technologies Private Limited | Ready to use dantrolene compositions |
| US12246028B2 (en) | 2018-11-27 | 2025-03-11 | Eagle Research Labs Limited | Use of dantrolene and dantrolene prodrugs to treat radiation exposure |
| US12605364B2 (en) | 2020-04-10 | 2026-04-21 | Eagle Pharmaceuticals, Inc. | Methods of treating SARS-CoV-2 infections |
-
2021
- 2021-04-08 AU AU2021254415A patent/AU2021254415A1/en active Pending
- 2021-04-08 WO PCT/US2021/026303 patent/WO2021207444A1/en not_active Ceased
- 2021-04-08 CA CA3174684A patent/CA3174684A1/en active Pending
- 2021-04-08 MX MX2022012707A patent/MX2022012707A/es unknown
- 2021-04-08 JP JP2022561996A patent/JP2023521162A/ja active Pending
- 2021-04-08 EP EP21722062.3A patent/EP4132516A1/en active Pending
- 2021-04-08 IL IL296518A patent/IL296518A/en unknown
- 2021-04-08 US US17/995,604 patent/US12582633B2/en active Active
- 2021-04-08 CN CN202180031027.5A patent/CN115916189A/zh active Pending
- 2021-04-08 KR KR1020227037111A patent/KR20220167292A/ko active Pending
- 2021-04-08 BR BR112022020107A patent/BR112022020107A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Antiviral effects of green tea EGCG and its potential application against COVID-19 | |
| Hiremath et al. | In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2 | |
| Warowicka et al. | Antiviral activity of berberine | |
| JP7802365B2 (ja) | ハンタウイルス感染症の処置のためのｍｅｋ阻害剤 | |
| Hegazy et al. | Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses | |
| Kovacikova et al. | Small-molecule inhibitors of chikungunya virus: mechanisms of action and antiviral drug resistance | |
| Salaria et al. | Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach | |
| Yang et al. | Resveratrol, sirtuins, and viruses | |
| Tang et al. | Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever | |
| JP2013537891A5 (https=) | ||
| Chowdhary et al. | Recent updates on viral oncogenesis: available preventive and therapeutic entities | |
| Dharmashekara et al. | Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection | |
| Pająk et al. | The antiviral effects of 2-deoxy-D-glucose (2-DG), a dual D-glucose and D-mannose mimetic, against SARS-CoV-2 and other highly pathogenic viruses | |
| JP2023521162A5 (https=) | ||
| Dutta et al. | Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study | |
| Sultan et al. | Potential of targeting host cell calcium dynamics to curtail SARS-CoV-2 infection and COVID-19 pathogenesis | |
| JP2023521163A5 (https=) | ||
| Pasquereau et al. | Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro | |
| Moharana et al. | Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study | |
| Tomaziu-Todosia Anton et al. | Oxidative stress, inflammation, and antioxidant strategies in cervical cancer—a narrative review | |
| Wang et al. | Antiviral activity of luteolin against porcine epidemic diarrhea virus in silico and in vitro | |
| Pandey et al. | A review on corona virus and treatment approaches with Allium sativam | |
| Kalam et al. | Emerging Therapeutics in the Fight Against EV‐D68: A Review of Current Strategies | |
| Gurung et al. | Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure | |
| Shahmohamadnejad et al. | May we target double‐membrane vesicles and oxysterol‐binding protein to combat SARS‐CoV‐2 infection? |